Laura Shawver
2020 - ARS Pharmaceuticals
In 2020, Laura Shawver earned a total compensation of $13.8M as Chief Executive Officer at ARS Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $283,545 |
|---|---|
| Option Awards | $13,166,894 |
| Salary | $324,811 |
| Other | $44,475 |
| Total | $13,819,725 |
Shawver received $13.2M in option awards, accounting for 95% of the total pay in 2020.
Shawver also received $283.5K in non-equity incentive plan, $324.8K in salary and $44.5K in other compensation.
Rankings
In 2020, Laura Shawver's compensation ranked 483rd out of 13,090 executives tracked by ExecPay. In other words, Shawver earned more than 96.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 483 out of 13,090 | 96th |
Division Manufacturing | 163 out of 5,618 | 97th |
Major group Chemicals And Allied Products | 57 out of 2,251 | 98th |
Industry group Drugs | 51 out of 1,951 | 97th |
Industry Pharmaceutical Preparations | 36 out of 1,456 | 98th |
Source: SEC filing on April 22, 2021.
Shawver's colleagues
We found three more compensation records of executives who worked with Laura Shawver at ARS Pharmaceuticals in 2020.
News
ARS Pharmaceuticals CEO Laura Shawver's 2022 pay jumps 608% to $5.8M
May 1, 2023
ARS Pharmaceuticals CEO Laura Shawver's 2021 pay falls 94% to $822K
April 28, 2022
ARS Pharmaceuticals CEO Laura Shawver receives $14M in 2020
April 22, 2021
Synthorx CEO Laura Shawver's 2018 pay jumps 3,349% to $5.2M
April 24, 2019